awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
10428194.2015.1091927
10428194.2015.1091927
http://dx.doi.org/10.3109/10428194.2015.1091927
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191.
P356
Q53817434-1958A652-B94B-47D7-A094-1109300423CD
P356
10428194.2015.1091927
http://dx.doi.org/10.3109/10428194.2015.1091927